Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 7/20 | 0.46 |
| ▸ | CDC25B | P30305 | 7/20 | 0.46 |
| ▸ | CDC25C | P30307 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 9/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6331066 | 1.00 | CDC25A (0.46) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| Fimbrolide SCHEMBL1049934 | 0.93 | CDC25A (0.38) | CDC25ACDC25BCDC25CALOX5 | |
| Fimbrolide SCHEMBL13668734 | 0.93 | CDC25A (0.38) | CDC25ACDC25BCDC25CALOX5 | |
| Fimbrolide SCHEMBL1049932 | 0.93 | CDC25A (0.38) | CDC25ACDC25BCDC25CALOX5 | |
| SCHEMBL4652230 | 0.87 | CDC25A (0.43) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL4652165 | 0.87 | CDC25A (0.43) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL4650435 | 0.87 | CDC25A (0.43) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL4650432 | 0.87 | CDC25A (0.43) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL4652232 | 0.87 | CDC25A (0.43) | CDC25ACDC25BCDC25CALDH1A1MAPT | |
| SCHEMBL4652162 | 0.87 | CDC25A (0.43) | CDC25ACDC25BCDC25CALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050215772-A1 | Furanone derivatives and methods of making same | BIOSIGNAL LIMITED (AT) | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215772-A1 | Furanone derivatives and methods of making same | PFAS, CFAP20, FDPS | CDC25A 4351/4885CDC25B 3902/4885CDC25C 4048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.